Literature DB >> 24176570

Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.

Allen E J Yeoh1, Daryl Tan, Chi-Kong Li, Hiroki Hori, Eric Tse, Ching-Hon Pui.   

Abstract

Survival for adults and children with acute lymphoblastic leukaemia has risen substantially in recent years because use of improved risk-directed treatments and supportive care has widened. In nearly all developed countries, multidisciplinary panels of leukaemia experts have formulated clinical practice guidelines in which standard treatment approaches are recommended on the basis of current evidence. However, those guidelines do not take into account resource limitations in low-income countries, including financial and technical challenges. In Asia, huge disparities in economy and infrastructure exist between countries, and even among different regions in some large countries. At a consensus session held as part of the 2013 Asian Oncology Summit in Bangkok, Thailand, a panel of experts summarised recommendations for management of adult and paediatric acute lymphoblastic leukaemia. Strategies were developed for Asian countries on the basis of available financial, skill, and logistical resources and were stratified in a four-tier system according to the resources available in a particular country or region (basic, limited, enhanced, and maximum).
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24176570      PMCID: PMC4059516          DOI: 10.1016/S1470-2045(13)70452-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  98 in total

1.  Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol.

Authors:  Marco Vignetti; Paola Fazi; Giuseppe Cimino; Giovanni Martinelli; Francesco Di Raimondo; Felicetto Ferrara; Giovanna Meloni; Achille Ambrosetti; Giovanni Quarta; Livio Pagano; Giovanna Rege-Cambrin; Loredana Elia; Raffaello Bertieri; Luciana Annino; Robin Foà; Michele Baccarani; Franco Mandelli
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

2.  Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Yousif Matloub; Bruce C Bostrom; Stephen P Hunger; Linda C Stork; Anne Angiolillo; Harland Sather; Mei La; Julie M Gastier-Foster; Nyla A Heerema; Scott Sailer; Patrick J Buckley; Blythe Thomson; Catherine Cole; James B Nachman; Gregory Reaman; Naomi Winick; William L Carroll; Meenakshi Devidas; Paul S Gaynon
Journal:  Blood       Date:  2011-05-11       Impact factor: 22.113

3.  ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.

Authors:  Heng Xu; Cheng Cheng; Meenakshi Devidas; Deqing Pei; Yiping Fan; Wenjian Yang; Geoff Neale; Paul Scheet; Esteban G Burchard; Dara G Torgerson; Celeste Eng; Michael Dean; Frederico Antillon; Naomi J Winick; Paul L Martin; Cheryl L Willman; Bruce M Camitta; Gregory H Reaman; William L Carroll; Mignon Loh; William E Evans; Ching-Hon Pui; Stephen P Hunger; Mary V Relling; Jun J Yang
Journal:  J Clin Oncol       Date:  2012-01-30       Impact factor: 44.544

4.  Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

Authors:  P S Gaynon; M E Trigg; N A Heerema; M G Sensel; H N Sather; G D Hammond; W A Bleyer
Journal:  Leukemia       Date:  2000-12       Impact factor: 11.528

5.  Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007.

Authors:  Benjamin O Anderson; Cheng-Har Yip; Robert A Smith; Roman Shyyan; Stephen F Sener; Alexandru Eniu; Robert W Carlson; Edward Azavedo; Joe Harford
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

6.  Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: addendum.

Authors: 
Journal:  Pediatrics       Date:  2002-10       Impact factor: 7.124

Review 7.  Current management and challenges of malignant disease in the CNS in paediatric leukaemia.

Authors:  Ching-Hon Pui; Scott C Howard
Journal:  Lancet Oncol       Date:  2008-03       Impact factor: 41.316

8.  Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

Authors:  Kirk R Schultz; W Paul Bowman; Alexander Aledo; William B Slayton; Harland Sather; Meenakshi Devidas; Chenguang Wang; Stella M Davies; Paul S Gaynon; Michael Trigg; Robert Rutledge; Laura Burden; Dean Jorstad; Andrew Carroll; Nyla A Heerema; Naomi Winick; Michael J Borowitz; Stephen P Hunger; William L Carroll; Bruce Camitta
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544

Review 9.  Integration of palliative care practices into the ongoing care of children with cancer: individualized care planning and coordination.

Authors:  Justin N Baker; Pamela S Hinds; Sheri L Spunt; Raymond C Barfield; Caitlin Allen; Brent C Powell; Lisa H Anderson; Javier R Kane
Journal:  Pediatr Clin North Am       Date:  2008-02       Impact factor: 3.278

10.  Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries.

Authors:  Monika L Metzger; Scott C Howard; Ligia C Fu; Armando Peña; Rene Stefan; Michael L Hancock; Zhe Zhang; Ching Hon Pui; Judy Wilimas; Raul C Ribeiro
Journal:  Lancet       Date:  2003-08-30       Impact factor: 79.321

View more
  22 in total

Review 1.  [Association between BIM gene and glucocorticoid resistance in children with acute lymphoblastic leukemia].

Authors:  Jin-Yun Xu; Jian-Ming Luo
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-08

Review 2.  Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.

Authors:  Alejandra Sanjuan-Pla; Clara Bueno; Cristina Prieto; Pamela Acha; Ronald W Stam; Rolf Marschalek; Pablo Menéndez
Journal:  Blood       Date:  2015-10-13       Impact factor: 22.113

3.  Clinical Characteristics and Outcomes of Acute Lymphoblastic Leukemia in Adolescents and Young Adults in Malawi.

Authors:  Edwards Kasonkanji; Stephen Kimani; Brent Skiver; Grace Ellis; Ryan Seguin; Bongani Kaimila; Tamiwe Tomoka; Maurice Mulenga; Nathan Montgomery; Yuri Fedoriw; Satish Gopal; Katherine D Westmorland; Matthew S Painschab
Journal:  JCO Glob Oncol       Date:  2022-06

Review 4.  Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.

Authors:  Ching-Hon Pui; Jun J Yang; Stephen P Hunger; Rob Pieters; Martin Schrappe; Andrea Biondi; Ajay Vora; André Baruchel; Lewis B Silverman; Kjeld Schmiegelow; Gabriele Escherich; Keizo Horibe; Yves C M Benoit; Shai Izraeli; Allen Eng Juh Yeoh; Der-Cherng Liang; James R Downing; William E Evans; Mary V Relling; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 5.  Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.

Authors:  Carlos Rodriguez-Galindo; Paola Friedrich; Patricia Alcasabas; Federico Antillon; Shripad Banavali; Luis Castillo; Trijn Israels; Sima Jeha; Mhammed Harif; Michael J Sullivan; Thuan Chong Quah; Catherine Patte; Ching-Hon Pui; Ronald Barr; Thomas Gross
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

6.  Wee1 kinase inhibitor MK-1775 induces apoptosis of acute lymphoblastic leukemia cells and enhances the efficacy of doxorubicin involving downregulation of Notch pathway.

Authors:  Yanchao Duan; Xin Dong; Jing Nie; Peng Li; Fei Lu; Daoxin Ma; Chunyan Ji
Journal:  Oncol Lett       Date:  2018-08-10       Impact factor: 2.967

7.  Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia.

Authors:  Naohito Fujishima; Toshiki Uchida; Yasushi Onishi; Chul Won Jung; Yeow Tee Goh; Kiyoshi Ando; Ming Chung Wang; Chiho Ono; Miyako Matsumizu; M Luisa Paccagnella; Barbara Sleight; Erik Vandendries; Yosuke Fujii; Masayuki Hino
Journal:  Int J Hematol       Date:  2019-11-13       Impact factor: 2.490

Review 8.  Acute leukemia in children: A review of the current Indian data.

Authors:  Ramandeep Singh Arora; Brijesh Arora
Journal:  South Asian J Cancer       Date:  2016 Jul-Sep

9.  Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

Authors:  Yukio Kobayashi; Iekuni Oh; Toshihiro Miyamoto; Won-Sik Lee; Hiroatsu Iida; Hironobu Minami; Yoshinobu Maeda; Jun Ho Jang; Sung-Soo Yoon; Su-Peng Yeh; Qui Tran; Joan Morris; Janet Franklin; Hitoshi Kiyoi
Journal:  Asia Pac J Clin Oncol       Date:  2021-06-29       Impact factor: 1.926

Review 10.  How do we prepare ourselves for a new paradigm of medicine to advance the treatment of pediatric acute lymphoblastic leukemia?

Authors:  Kyung Duk Park
Journal:  Blood Res       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.